Literature DB >> 16139271

Fluoxetine (Prozac) interaction with the mitochondrial voltage-dependent anion channel and protection against apoptotic cell death.

Edna Nahon1, Adrian Israelson, Salah Abu-Hamad, Shoshan-Barmatz Varda.   

Abstract

Fluoxetine (Prozac) is a potent antidepressant compound inhibiting serotonin reuptake, but also Na+, K+ and Ca2+ channels and reported to both trigger and prevent apoptosis. Recently, fluoxetine was found to increase the voltage sensitivity of the mitochondrial voltage-dependent anion channel (VDAC). VDAC which functions in transporting metabolites across the mitochondria also plays a crucial role in apoptosis. Here, we demonstrate that fluoxetine interacted with VDAC and decreased its conductance. Fluoxetine inhibited the opening of the mitochondrial permeability transition pore, the release of cytochrome c, and protected against staurosporine-induced apoptotic cell death. These findings may explain some of the reported fluoxetine side effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16139271     DOI: 10.1016/j.febslet.2005.08.020

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  32 in total

Review 1.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

2.  Approaching the structure of human VDAC1, a key molecule in mitochondrial cross-talk.

Authors:  Kornelius Zeth; Thomas Meins; Clemens Vonrhein
Journal:  J Bioenerg Biomembr       Date:  2008-06       Impact factor: 2.945

Review 3.  A mitochondrial bioenergetic basis of depression.

Authors:  N Jennifer Klinedinst; William T Regenold
Journal:  J Bioenerg Biomembr       Date:  2014-09-28       Impact factor: 2.945

Review 4.  Pharmacological modulation of mitochondrial ion channels.

Authors:  Luigi Leanza; Vanessa Checchetto; Lucia Biasutto; Andrea Rossa; Roberto Costa; Magdalena Bachmann; Mario Zoratti; Ildiko Szabo
Journal:  Br J Pharmacol       Date:  2019-01-02       Impact factor: 8.739

5.  Effects of Antidepressants on DSP4/CPT-Induced DNA Damage Response in Neuroblastoma SH-SY5Y Cells.

Authors:  Yan Wang; Benjamin A Hilton; Kui Cui; Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2015-06-03       Impact factor: 3.911

6.  Interaction of paroxetine with mitochondrial proteins mediates neuroprotection.

Authors:  Joseph P Steiner; Muznabanu Bachani; Brett Wolfson-Stofko; Myoung-Hwa Lee; Tongguang Wang; Tonguang Wang; Guanhan Li; Wenxue Li; David Strayer; Norman J Haughey; Avindra Nath
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

7.  Vulnerability for apoptosis in the limbic system after myocardial infarction in rats: a possible model for human postinfarct major depression.

Authors:  Boubacar Pasto Wann; Thierno Madjou Bah; Matthieu Boucher; Jérôme Courtemanche; Nathalie Le Marec; Guy Rousseau; Roger Godbout
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

8.  Anti-ceramidase LCL385 acutely reduces BCL-2 expression in the hippocampus but is not associated with an increase of learned helplessness in rats.

Authors:  Ziad Nahas; Yan Jiang; Youssef H Zeidan; Alicja Bielawska; Zdzislaw Szulc; Lindsay Devane; Peter Kalivas; Yusuf A Hannun
Journal:  Behav Brain Res       Date:  2008-08-14       Impact factor: 3.332

9.  Quinidine partially blocks mitochondrial voltage-dependent anion channel (VDAC).

Authors:  Chetan Malik; Subhendu Ghosh
Journal:  Eur Biophys J       Date:  2020-03-09       Impact factor: 1.733

Review 10.  Nanotechnology inspired tools for mitochondrial dysfunction related diseases.

Authors:  Ru Wen; Bhabatosh Banik; Rakesh K Pathak; Anil Kumar; Nagesh Kolishetti; Shanta Dhar
Journal:  Adv Drug Deliv Rev       Date:  2016-01-09       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.